Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity

被引:40
作者
Frost, Hannah R. [1 ,2 ]
Laho, Delphine [1 ,3 ]
Sanderson-Smith, Martina L. [4 ,5 ]
Licciardi, Paul [6 ,7 ]
Donath, Susan [7 ]
Curtis, Nigel [7 ]
Kado, Joseph [8 ,9 ,10 ]
Dale, James B. [11 ,12 ,13 ]
Steer, Andrew C. [1 ,7 ,14 ]
Smeesters, Pierre R. [1 ,2 ,3 ,14 ]
机构
[1] Murdoch Childrens Res Inst, Grp Streptococcus Res Grp A, Melbourne, Vic, Australia
[2] Univ Libre Bruxelles, Acad Children Hosp Queen Fabiola, Mol Bacteriol Lab, Brussels, Belgium
[3] Univ Libre Bruxelles, Acad Children Hosp Queen Fabiola, Dept Pediat, Brussels, Belgium
[4] Univ Wollongong, Illawarra Hlth & Med Res Inst, Melbourne, Vic, Australia
[5] Univ Wollongong, Sch Biol Sci, Melbourne, Vic, Australia
[6] Murdoch Childrens Res Inst, Pneumococcal Res Grp, Melbourne, Vic, Australia
[7] Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Parkville, Vic, Australia
[8] Colonial War Mem Hosp, Dept Paediat, Suva, Fiji
[9] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Suva, Fiji
[10] Fiji Rheumat Heart Dis Control Program, Suva, Fiji
[11] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA
[12] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA
[13] Dept Vet Affairs Med Ctr, Memphis, TN USA
[14] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
Streptococcus pyogenes; emm-cluster; immunity; vaccine; skin infection; ACUTE RHEUMATIC-FEVER; M PROTEIN; BACTERICIDAL ACTIVITY; OPSONIC ANTIBODIES; GENETIC DIVERSITY; VACCINE; SERUM; ASSAY; COMPLEMENT; RESPONSES;
D O I
10.1093/cid/cix599
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Group A Streptococcus (GAS) skin infections are particularly prevalent in developing nations. The GAS M protein, by which strains are differentiated into >220 different emm types, is immunogenic and elicits protective antibodies. A major obstacle for vaccine development has been the traditional understanding that immunity following infection is restricted to a single emm type. However, recent evidence has led to the hypothesis of immune cross-reactivity between emm types. Methods. We investigated the human serological response to GAS impetigo in Fijian schoolchildren, focusing on 3 major emm clusters (E4, E6, and D4). Pre-and postinfection sera were assayed by enzyme-linked immunosorbent assay with N-terminal M peptides and bactericidal assays using the infecting-type strain, emm cluster-related strains, and nonrelated strains. Results. Twenty of the 53 paired sera demonstrated a >= 4-fold increase in antibody titer against the infecting type. When tested against all cluster-related M peptides, we found that 9 of 17 (53%) paired sera had a >= 4-fold increase in antibody titer to cluster-related strains as well. When grouped by cluster, the mean change to cluster-related emm types in E4 and E6 was >= 4-fold (5.9-fold and 19.5-fold, respectively) but for D4 was 3.8-fold. The 17 paired sera were tested in bactericidal assays against selected cluster-related and nonrelated strains. While the responses were highly variable, numerous instances of cross-reactive killing were observed. Conclusions. These data demonstrate that M type-specific and cross-reactive immune responses occur following skin infection. The cross-reactive immune responses frequently align with emm clusters, raising new opportunities to design multivalent vaccines with broad coverage.
引用
收藏
页码:1523 / 1531
页数:9
相关论文
共 40 条
[1]   The emm-Cluster Typing System for Group A Streptococcus Identifies Epidemiologic Similarities Across the Pacific Region [J].
Baroux, Noemie ;
D'Ortenzio, Eric ;
Amedeo, Nathalie ;
Baker, Ciara ;
Alsuwayyid, Barakat Ali ;
Dupont-Rouzeyrol, Myrielle ;
O'Connor, Olivia ;
Steer, Andrew ;
Smeesters, Pierre R. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (07) :E84-E92
[2]   Development and Use of a Serum Bactericidal Assay Using Pooled Human Complement To Assess Responses to a Meningococcal Group A Conjugate Vaccine in African Toddlers [J].
Bash, Margaret C. ;
Lynn, Freyja ;
Mocca, Brian ;
Borrow, Ray ;
Findlow, Helen ;
Hassan-King, Musa ;
Preziosi, Marie-Pierre ;
Idoko, Olubukola ;
Sow, Samba ;
Kulkarni, Prasad ;
LaForcec, F. Marc .
CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (05) :755-761
[3]   TYPE-SPECIFIC OPSONIC ANTIBODIES IN STREPTOCOCCAL PYODERMA [J].
BISNO, AL ;
NELSON, KE .
INFECTION AND IMMUNITY, 1974, 10 (06) :1356-1361
[4]   The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma [J].
Bowen, Asha C. ;
Mahe, Antoine ;
Hay, Roderick J. ;
Andrews, Ross M. ;
Steer, Andrew C. ;
Tong, Steven Y. C. ;
Carapetis, Jonathan R. .
PLOS ONE, 2015, 10 (08)
[5]   The global burden of group A streptococcal diseases [J].
Carapetis, JR ;
Steer, AC ;
Mulholland, EK ;
Weber, M .
LANCET INFECTIOUS DISEASES, 2005, 5 (11) :685-694
[6]  
Courtney HS, 2017, CLIN EXP VACCINE RES, V6, P45, DOI [10.7774/cevr.2017.6.1.45., 10.7774/cevr.2017.6.1.45]
[7]   Structure-based design of broadly protective group a streptococcal M protein-based vaccines [J].
Dale, James B. ;
Smeesters, Pierre R. ;
Courtney, Harry S. ;
Penfound, Thomas A. ;
Hohn, Claudia M. ;
Smith, Jeremy C. ;
Baudry, Jerome Y. .
VACCINE, 2017, 35 (01) :19-26
[8]   Potential coverage of a multivalent M protein-based group A streptococcal vaccine [J].
Dale, James B. ;
Penfound, Thomas A. ;
Tamboura, Boubou ;
Sow, Samba O. ;
Nataro, James P. ;
Tapia, Milagritos ;
Kotloff, Karen L. .
VACCINE, 2013, 31 (12) :1576-1581
[9]   New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci [J].
Dale, James B. ;
Penfound, Thomas A. ;
Chiang, Edna Y. ;
Walton, William J. .
VACCINE, 2011, 29 (46) :8175-8178
[10]   HETEROGENEITY OF TYPE-SPECIFIC AND CROSS-REACTIVE ANTIGENIC DETERMINANTS WITHIN A SINGLE M PROTEIN OF GROUP A STREPTOCOCCI [J].
DALE, JB ;
OFEK, I ;
BEACHEY, EH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (05) :1026-1038